Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like Agenda – CVMP agenda of the 15-17 March 2022 meeting Agenda and registration form – EMA EudraVigilance information day Agenda – PDCO agenda of the 22-25 March 2022 meeting
